Biocidal fibrous and film materials utilizing silver ion

Patent metadata

Field	Value
Publication number	US-9364579-B2
Application number	US-21573905-A
Country	US
Kind code	B2
Filing date	Aug 30, 2005
Priority date	Aug 30, 2004
Publication date	Jun 14, 2016
Grant date	Jun 14, 2016

Abstract

Disclosed are compositions comprising a hydrophilic polymer, a hydrophobic polymer, and a silver ion, wherein the silver ion associates with at least one hydrophilic or hydrophobic polymer, and wherein the composition does not comprise an effective amount of a chlorite ion. Also disclosed are methods of making a photo-stable silver ion containing wound dressing and methods of reducing or preventing infection of a wound by using the compositions and wound dressings of the present invention.

First claim

What is claimed is:

1. A biocidal composition comprising:
a transparent compatible blend of a hydrophilic polymer and a hydrophobic polymer containing
(a) a first silver ion chemically bonded to an ionized carboxylate group or a quaternary nitrogen group of said hydrophilic polymer resulting from a water washed mixture of a first silver salt having a first water soluble anion and a hydrophilic polymer having a carboxylate salt of a first water soluble cation, wherein said first water soluble anion and first water soluble cation have been removed from the mixture and been concentrated in the water, said quaternary nitrogen having a halogen anion; and
(b) a second silver ion chemically bonded to an ionized carboxylate group of said hydrophobic polymer resulting from a water washed mixture of a second silver salt having a second water soluble anion and a hydrophilic polymer having a carboxylate salt of a second water soluble cation, wherein said second water soluble anion and second water soluble cation have been removed from the mixture and been concentrated into the water;
wherein said hydrophilic polymer and hydrophobic polymer provide different binding potential for said first and second silver ions; and
wherein the composition does not comprise an effective amount of chlorite ions; and
wherein said first silver ion has a different rate of release from said hydrophilic polymer than said second silver ions from said hydrophobic polymer.

2. The composition of claim 1 , wherein at least one of said first or second silver ions bridges at least one hydrophilic polymer strand with at least one hydrophobic polymer strand.

3. The composition of claim 1 , wherein the first and second silver ions are chemically bonded to said polymers by an ionic bond or a co-ordinate bond.

4. The composition of claim 1 , wherein the halogen anion is Cl − , I − , Br − , or F − .

5. The composition of claim 1 , wherein the first and second silver salts are AgBF 4 , AgPF 6 , AgSO 3 CF 3 , AgClO 4 , AgNO 3 , n-alkylArSO 2 Ag, or n-alkylCOOAg.

6. The composition of claim 1 , wherein the composition comprises 1% to 10% by weight of silver ions.

7. The composition of claim 1 , wherein the composition comprises 20% to 80% by weight of hydrophilic polymer.

8. The composition of claim 1 , wherein the compositions comprises 20% to 80% by weight of a hydrophobic polymer.

9. The composition of claim 1 , wherein the hydrophilic polymer and the hydrophobic polymer are provided in a hydrophilic/hydrophobic polymer weight ratio which is 1/4 to 4/1.

10. The composition of claim 1 , wherein the composition is a controlled release silver ion composition.

11. The composition of claim 1 , wherein the composition is comprised on the surface of a medical device.

12. The composition of claim 11 , wherein the medical device is a scalpel, a tong, a retractor, or a glove.

13. The composition of claim 1 , wherein the composition is comprised in a wound dressing.

14. The composition of claim 1 , wherein the composition is a wound dressing.

15. The composition of claim 1 , wherein the hydrophilic polymer contains said quaternary nitrogen and comprises polymers of a vinyl pyridine, a vinyl imidazole, N-vinylpyrrolidone, N,N-dimethylacrylamide, N-vinylacetamide, or ethyl oxazoline.

16. The composition of claim 1 , wherein the silver ions are photo-stable or thermo-stable.

17. A biocidal wound dressing comprising:
a transparent compatible blend of a hydrophilic polymer and a hydrophobic polymer containing
(a) a first silver ion chemically bonded to an ionized carboxylate group or a quaternary nitrogen of said hydrophilic polymer resulting from a water washed mixture of a first silver salt having a first water soluble anion and a hydrophilic polymer having a carboxylate salt of a first water soluble cation, wherein said first water soluble anion and first water soluble cation have been removed from the mixture and been concentrated in the water, said quaternary nitrogen having an anion; and
(b) a second silver ion chemically bonded to an ionized carboxylate group of said hydrophobic polymer resulting from a water washed mixture of a second silver salt having a second water soluble anion and a hydrophilic polymer having a carboxylate salt of a second water soluble cation, wherein said second water soluble anion and second water soluble cation have been removed from the mixture and been concentrated into the water;
wherein said hydrophilic polymer and hydrophobic polymer provide different binding potential for said silver ions; and
wherein the wound dressing does not comprise an effective amount of a chlorite ion; and
wherein said first silver ion has a different rate of release from said hydrophilic polymer than said second silver ions from said hydrophobic polymer; and
wherein the dressing is produced from electrospinning.

Assignees

• Wellinghoff Stephen T
• Southwest Res Inst

Inventors

• Wellinghoff Stephen T

Classifications

• A61L15/46 Primary

  Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria · CPC title

• A61L2300/404

  Biocides, antimicrobial agents, antiseptic agents · CPC title

• A61K9/0024

  Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue (compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L) · CPC title

• A61K33/38

  Silver; Compounds thereof · CPC title

• A61L2300/104

  Silver, e.g. silver sulfadiazine · CPC title